Mine Harada
Karatsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial.
Journal: Cancer science
Published: October 12, 2025
A comparative study of GVHD prophylaxis using low dose ATG versus PTCy for PBSCT based on two independent prospective cohorts.
Journal: Scientific reports
Published: January 30, 2025
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.
Journal: Cancer science
Published: January 14, 2024
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.
Journal: Bone marrow transplantation
Published: August 06, 2023
Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.
Journal: International journal of hematology
Published: March 17, 2021
Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
Journal: Bone marrow transplantation
Published: June 23, 2020
Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Journal: Bone marrow transplantation
Published: April 27, 2020
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies.
Journal: International journal of hematology
Published: March 09, 2020
Prognostic significance of red cell distribution width in hospitalized older patients with heart failure or infection.
Journal: Geriatrics & gerontology international
Published: May 10, 2019
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).
Journal: International journal of clinical oncology
Published: December 28, 2018
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Journal: Arthritis research & therapy
Published: November 10, 2018
Last Updated: 09/26/2026